Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era

被引：8

作者：

Bedognetti, Davide ^{[1
,2
]}

Zoppoli, Gabriele ^{[3
,4
]}

Sertoli, Mario Roberto ^{[2
,5
]}

Zanardi, Elisa ^{[2
]}

Blandini, Pietro ^{[3
]}

Uccellini, Lorenzo ^{[1
]}

Boccardo, Francesco ^{[2
,5
]}

Andreoli, Giovanni Battista ^{[6
]}

Ghio, Riccardo ^{[3
]}

Racchi, Omar ^{[2
,7
]}

Ferrarini, Manlio ^{[2
,5
]}

De Maria, Andrea ^{[3
,5
,8
]}

机构：

[1] Natl Inst Hlth, Infect Dis & Immunogenet Sect, Dept Transfus Med, Bethesda, MD 20892 USA

[2] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy

[3] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy

[4] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[5] Natl Inst Canc Res, Dept Med Oncol, Genoa, Italy

[6] Natl Inst Canc Res, Direz Sanit, Genoa, Italy

[7] Villa Scassi Hosp, Dept Internal Med, Genoa, Italy

[8] Natl Inst Canc Res, Infect Dis Sect, Genoa, Italy

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2010年 / 91卷 / 02期

关键词：

HEPATITIS-B; MALIGNANT-LYMPHOMA; REACTIVATION;

D O I：

10.1007/s12185-010-0522-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：342 / 344

页数：3

共 12 条

[1] Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier [J].

Fukushima, N. ;

Mizuta, T. ;

Tanaka, M. ;

Yokoo, M. ;

Ide, M. ;

Hisatomi, T. ;

Kuwahara, N. ;

Tomimasu, R. ;

Tsuneyoshi, N. ;

Funai, N. ;

Sueoka, E. .

ANNALS OF ONCOLOGY, 2009, 20 (12) :2013-2017

[2] Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma [J].

Kusumoto, Shigeru ;

Tanaka, Yasuhito ;

Mizokami, Masashi ;

Ueda, Ryuzo .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (01) :13-23

[3] Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies [J].

Lalazar, Gadi ;

Rund, Deborah ;

Shouval, Daniel .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (05) :699-712

[4] Therapeutic implications of hepatitis B virus genotypes [J].

Liu, CJ ;

Kao, JH ;

Chen, DS .

LIVER INTERNATIONAL, 2005, 25 (06) :1097-1107

[5] REACTIVATION OF HEPATITIS-B VIRUS-REPLICATION IN PATIENTS RECEIVING CYTOTOXIC THERAPY - REPORT OF A PROSPECTIVE-STUDY [J].

LOK, ASF ;

LIANG, RHS ;

CHIU, EKW ;

WONG, KL ;

CHAN, TK ;

TODD, D .

GASTROENTEROLOGY, 1991, 100 (01) :182-188

[6] Prophylaxis and treatment of hepatitis B in immunocompromised patients [J].

Marzano, A. ;

Angelucci, E. ;

Andreone, P. ;

Brunetto, M. ;

Bruno, R. ;

Burra, P. ;

Caraceni, P. ;

Daniele, B. ;

Di Marco, V. ;

Fabrizi, F. ;

Fagiuoli, S. ;

Grossi, P. ;

Lampertico, P. ;

Meliconi, R. ;

Mangia, A. ;

Puoti, M. ;

Raimondo, G. ;

Smedile, A. .

DIGESTIVE AND LIVER DISEASE, 2007, 39 (05) :397-408

[7] A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma [J].

Molina, Arturo .

ANNUAL REVIEW OF MEDICINE, 2008, 59 :237-250

[8]

PEI SN, 2009, ANN HEMATOL

[9]

Targhetta C, 2008, Haematologica, V93, pe66, DOI 10.3324/haematol.13750

[10] Rituximab treatment results in impaired secondary humoral immune responsiveness [J].

van der Kolk, LE ;

Baars, JW ;

Prins, MH ;

van Oers, MHJ .

BLOOD, 2002, 100 (06) :2257-2259

← 1 2 →